Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39.71	45.82	7.27	8.19	20.3	16.74
Short-Term Investments	14.84	14.4	-	4.93	-	-
Cash & Short-Term Investments	54.55	60.21	7.27	13.12	20.3	16.74
Cash Growth	520.39%	728.67%	-44.62%	-35.38%	21.31%	26.66%
Other Current Assets	0.52	0.08	0.07	0.05	0.22	0.06
Total Current Assets	55.08	60.29	7.33	13.17	20.52	16.8
Property, Plant & Equipment	0.01	-	0.01	0.06	-	-
Other Long-Term Assets	-	-	-	-	-	0.07
Total Assets	55.09	60.29	7.35	13.23	20.52	16.87
Accounts Payable	1.49	2.25	1.76	3.13	1.58	1.18
Accrued Expenses	-	3	-	-	-	-
Total Current Liabilities	1.49	5.25	1.76	3.13	1.58	1.18
Long-Term Leases	-	-	-	0.01	-	-
Total Liabilities	1.49	5.25	1.76	3.14	1.58	1.18
Common Stock	0.01	0.01	0	0.01	0.01	0.01
Additional Paid-In Capital	132.03	130.79	65.81	61.87	60.22	47.87
Retained Earnings	-78.42	-75.79	-60.21	-51.8	-41.29	-32.19
Comprehensive Income & Other	-0.02	0.04	-0.01	0.01	-0	-0.01
Total Common Equity	53.59	55.04	5.59	10.09	18.94	15.69
Shareholders' Equity	53.59	55.04	5.59	10.09	18.94	15.69
Total Liabilities & Equity	55.09	60.29	7.35	13.23	20.52	16.87
Total Debt	-	-	-	0.01	-	-
Net Cash (Debt)	54.55	60.21	7.27	13.11	20.3	16.74
Net Cash Growth	520.39%	728.67%	-44.58%	-35.42%	21.31%	26.66%
Net Cash Per Share	11.51	15.89	2.63	5.15	8.14	7.64
Filing Date Shares Outstanding	6.12	6.11	3.49	2.64	2.52	2.51
Total Common Shares Outstanding	6.12	6.1	2.98	2.59	2.52	2.29
Working Capital	53.58	55.04	5.58	10.04	18.94	15.62
Book Value Per Share	8.76	9.02	1.87	3.90	7.52	6.85
Tangible Book Value	53.59	55.04	5.59	10.09	18.94	15.69
Tangible Book Value Per Share	8.76	9.02	1.87	3.90	7.52	6.85

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q